| Document and Entity Information - USD ($) | 12 Months Ended | |
| Dec. 31, 2018 | Jun. 30, 2018 | |
| Document and Entity Information: | ||
| Entity Registrant Name | Kreido Biofuels, Inc. | |
| Document Type | 10-K | |
| Document Period End Date | Dec. 31, 2018 | |
| Trading Symbol | krdo | |
| Amendment Flag | false | |
| Entity Central Index Key | 0001342219 | |
| Current Fiscal Year End Date | --12-31 | |
| Entity Common Stock, Shares Outstanding | 118,720,992 | |
| Entity Public Float | $ 118,720,992 | |
| Entity Filer Category | Non-accelerated Filer | |
| Entity Current Reporting Status | No | |
| Entity Voluntary Filers | No | |
| Entity Well-known Seasoned Issuer | No | |
| Document Fiscal Year Focus | 2018 | |
| Document Fiscal Period Focus | FY |
| Consolidated Balance Sheets - USD ($) | Dec. 31, 2018 | Dec. 31, 2017 |
| CURRENT ASSETS | ||
| Due from Related Party | $ 3,973 | |
| Prepaid Expenses | 2,000 | |
| Total Current Assets | 5,973 | |
| TOTAL ASSETS | 5,973 | |
| CURRENT LIABILITIES | ||
| Accounts Payable | $ 12,225 | 900 |
| Related Party Payable | 12,233 | |
| Note Payable - Short Term | 4,208 | |
| Total Current Liabilities | 24,458 | 5,108 |
| LONG TERM LIABILITIES | ||
| Note Payable - Long Term | 7,715 | |
| Total Long Term Liabilities | 7,715 | |
| Total Liabilities | 24,458 | 12,823 |
| STOCKHOLDERS' DEFICIT | ||
| Common stock; 300,000,000 shares authorized,at $0.001 par value, 195,645,159shares issued and outstanding | 195,645 | 195,645 |
| Additional paid-in capital | 48,791,188 | 48,769,838 |
| Accumulated Deficit | (49,011,291) | (48,972,333) |
| Total Stockholders' Deficit | $ (24,458) | (6,850) |
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | $ 5,973 |
| Consolidated Statements of Operations - USD ($) | 12 Months Ended | |
| Dec. 31, 2018 | Dec. 31, 2017 | |
| EXPENSES | ||
| Professional Fees | $ 34,342 | $ 2,400 |
| General and administrative | 4,616 | 20,010 |
| Total operating expenses | 38,958 | 22,410 |
| OTHER INCOME/EXPENSE | ||
| Gain on settlement of debt | (1,616) | |
| Total other income/(expense) | (1,616) | |
| Total Expenses | 38,958 | 20,794 |
| LOSS FROM OPERATIONS | (38,958) | (20,794) |
| OTHER EXPENSES | ||
| Gain from discontinued operations | 5,800 | |
| Total Other Expenses | 5,800 | |
| LOSS BEFORE INCOME TAXES | (38,958) | (14,994) |
| NET INCOME (LOSS) | $ (38,958) | $ (14,994) |
| BASIC AND DILUTED LOSS PER SHARE | $ 0 | $ 0 |
| BASIC AND DILUTED WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING | 72,691,218 | 72,691,218 |
| Consolidated Statements of Cash Flows - USD ($) | 12 Months Ended | |
| Dec. 31, 2018 | Dec. 31, 2017 | |
| CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Profit (loss) | $ (38,958) | $ (14,994) |
| Adjustments to reconcile net loss to net cash used in operating activities: | ||
| Gain on discontinued operations | 1,616 | |
| Changes in operating assets and liabilities: | ||
| Change in prepaid expenses | 2,000 | (2,000) |
| Change in notes payable - Short term | 3,973 | (3,973) |
| Change in accounts payable related party | 12,233 | (1,382) |
| Change in accounts payable | 11,325 | |
| Net Cash Used in Operating Activities | (9,427) | (20,733) |
| CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Repayments on note payable | (11,923) | (702) |
| Proceeds from related party | 21,350 | 21,435 |
| Net Cash Provided by Financing Activities | $ 9,427 | $ 20,733 |
| Note 1 - Organization and Business Operations | 12 Months Ended |
| Dec. 31, 2018 | |
| Notes | |
| Note 1 - Organization and Business Operations | NOTE 1 - ORGANIZATION AND BUSINESS OPERATIONS Nature of Business Kreido Biofuels, Inc. was incorporated as Gemwood Productions, Inc. under the laws of the State of Nevada on February 7, 2005. Gemwood Productions, Inc. changed its name to Kreido Biofuels, Inc. on November 2, 2006. The Company took its current form on January 12, 2007 when Kreido Laboratories (Kreido Labs), completed a reverse triangular merger with Kreido Biofuels, Inc. Kreido Labs, formerly known as Holl Technologies Company, was incorporated on January 13, 1995 under the laws of the State of California. Since incorporation, Kreido Labs has been engaged in activities required to develop, patent and commercialize its products. Kreido Labs was the creator of reactor technology that was designed to enhance the manufacturing of a broad range of chemical products. The cornerstone of Kreido Labs technology was its patented STT ® ® |
| Note 2 - Summary of Significant Accounting Policies | 12 Months Ended |
| Dec. 31, 2018 | |
| Notes | |
| Note 2 - Summary of Significant Accounting Policies | NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America. Principles of Consolidation The accompanying consolidated financial statements for the years ended December 31, 2018 and 2017 include the accounts of the Company and its wholly-owned subsidiary, Kreido Laboratories, Inc. All significant intercompany balances and transactions have been eliminated in consolidation. Accounting Estimates The preparation of the financial statements in conformity with generally accepted accounting principles in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Fair Value of Financial Instruments Financial instruments, including cash and accrued expenses and other liabilities are carried at amounts, which reasonably approximate their fair value due to the short-term nature of these amounts or due to variable rates of interest, which are consistent with market rates. Loss per Common Share Basic loss per share is calculated by dividing the Companys net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Companys net income available to common shareholders by the diluted weighted average number of shares outstanding during the year. Cash and Cash Equivalents The Company considers all highly liquid investment with an original maturity of three months or less to be cash equivalents. At December 31, 2018 and 2017, cash and cash equivalents include cash on hand and cash in the bank. Stock-based compensation The Company recognizes compensation expense for all stock-based compensation awards based on the grant-date fair value estimated in accordance with the provisions of ASC 718. Income Taxes Under ASC 740, Income Taxes, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are established when it is more likely than not that some or all of the deferred tax assets will not be realized. As of December 31, 2018 there were no deferred taxes as there was a full valuation allowance due to the uncertainty of the realization of net operating loss or carry forward prior to expiration. Fair Value of Financial Instruments The Company follows guidance for accounting for fair value measurements of nonfinancial items that are recognized or disclosed at fair value in the financial statements on a recurring basis. Additionally, the Company adopted guidance for fair value measurement related to nonfinancial items that are recognized and disclosed at fair value in the financial statements on a nonrecurring basis. The guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to measurements involving significant unobservable inputs (Level 3 measurements). The three levels of the fair value hierarchy are as follows: Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. Level 2 inputs are inputs other than quoted prices included within Level 1that are observable for the asset or liability, either directly or indirectly. Level 3 inputs are unobservable inputs for the asset or liability. The carrying amounts of financial assets such as cash approximate their fair values because of the short maturity of these instruments. Recent Accounting Pronouncements The FASB established the Accounting Standards Codification (Codification or ASC) as the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of financial statements in accordance with generally accepted accounting principles in the United States (GAAP). Rules and interpretative releases of the Securities and Exchange Commission (SEC) issued under authority of federal securities laws are also sources of GAAP for SEC registrants. Other accounting standards that have been issued or proposed by FASB that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption. The Company does not discuss recent pronouncements that are not anticipated to have an impact on or are unrelated to its financial condition, results of operations, cash flows or disclosures. |
| Note 3 - Going Concern | 12 Months Ended |
| Dec. 31, 2018 | |
| Notes | |
| Note 3 - Going Concern | NOTE 3 - GOING CONCERN In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management's plan is to obtain such resources for the Company by obtaining capital from management sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However, Management cannot provide any assurances that the Company will be successful in accomplishing any of its plans, which raises substantial doubt about the ability of the Company to continue as a going concern. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. |
| Note 4 - Stockholders' Equity | 12 Months Ended |
| Dec. 31, 2018 | |
| Notes | |
| Note 4 - Stockholders' Equity | NOTE 4 STOCKHOLDERS EQUITY Common Stock The Companys Articles of Incorporation authorize the issuance of up to 300,000,000 common shares, par value $0.001 per share, and 10,000,000 preferred shares, also $.0001 par value. There were 195,645,159 shares of common stock outstanding at December 31, 2018 and 2017, respectively. There were no preferred shares outstanding during any periods presented. 2017 Equity Issuances On November 10, 2017, the Company issued to a related party 142,924,167 shares of stock in conversion of $150,074 of debt and $21,435 of accounts payable related party for payment of the Companys expenses. |
| Note 5 - Income Taxes | 12 Months Ended |
| Dec. 31, 2018 | |
| Notes | |
| Note 5 - Income Taxes | NOTE 5 INCOME TAXES On December 22, 2017, the 2017 Tax Cuts and Jobs Act (the Tax Act) was enacted into law including a one-time mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to 21% effective January 1, 2018, among others. We are required to recognize the effect of the tax law changes in the period of enactment, such as determining the transition tax, remeasuring our U.S. deferred tax assets and liabilities as well as reassessing the net realizability of our deferred tax assets and liabilities. The Company does not have any foreign earnings and therefore, we do not anticipate the impact of a transition tax. We have remeasured our U.S. deferred tax assets at a statutory income tax rate of 21%. Since the Tax Act was passed late in the fourth quarter of 2017, and ongoing guidance and accounting interpretation are expected over the next 12 months, we consider the accounting of any transition tax, deferred tax re-measurements, and other items to be incomplete due to the forthcoming guidance and our ongoing analysis of final year-end data and tax positions. We expect to complete our analysis within the measurement period in accordance with SAB 118, no later than 2019. The cumulative tax effect at the expected rate of 21% as of December 31, 2018 and December 31, 2017 of significant items comprising our net deferred tax amount is as follows: 2018 2017 Net operating loss carryover 49,011,291 $ 48,972,333 Deferred tax asset 10,292,371 10,284,190 Less: valuation allowance (10,292,371) (10,284,190) Net deferred tax asset $ - $ - At December 31, 2018, the Company had net operating loss carry forwards of approximately $49,011,291 that may be offset against future taxable income through 2038. No tax benefit has been reported in the December 31, 2018, consolidated financial statements since the potential tax benefit is offset by a valuation allowance of the same amount. The Company recognizes interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards for federal income tax reporting purposes are subject to annual limitations. A change in ownership may limit net operating loss carry forwards in future years. The last three years of tax returns are open for examination by taxing authorities. |
| Note 6 - Related Party Transactions | 12 Months Ended |
| Dec. 31, 2018 | |
| Notes | |
| Note 6 - Related Party Transactions | NOTE 6 RELATED PARTY TRANSACTIONS As of December 31, 2018, the Company has a related party payable in the amount of $12,233. At the year ended December 31, 2017, the Company had a related party receivable in the amount of $3,973. As mentioned in Note 4, the Company issued 142,924,167 shares of common stock valued at $171,509 for conversion of debt and related party payables. The related party payable is a shareholder in the Company. The related party payable of $21,435 was comprised of various accounts payable balances that the related party agreed to pay on behalf of the Company. As of December 31, 2017, the related party had paid down $17,462 of the outstanding balances, leaving a receivable of $3,973. During the six months ended June 30, 2018, a related party paid a total of $21,350 for professional fees and paying off outstanding note payable balances on behalf of the Company. On April 10, 2018, the related party, Reed Peterson, forgave his related party debt in the amount of $21,350. The forgiveness was recorded in additional paid-in capital. |
| Note 7- Note Payable | 12 Months Ended |
| Dec. 31, 2018 | |
| Notes | |
| Note 7- Note Payable | NOTE 7 NOTE PAYABLE The Company issued a note payable to its transfer agent in November 2017 in the amount of $12,625 in satisfaction of past due amounts due to the transfer agent. The Note requires payments of $526 per month for 24 months and is non-interest bearing. On June 28, 2018, the Note was paid off in full. |
| Note 8 - Subsequent Events | 12 Months Ended |
| Dec. 31, 2018 | |
| Notes | |
| Note 8 - Subsequent Events | NOTE 8 SUBSEQUENT EVENTS The Company has evaluated subsequent events from December 31, 2018 through the date the financial statements were issued and there have been no subsequent events for which disclosure is required. |
